Soubrié C[au] - Search Results

Year	Number of Results
1975	1
1978	1
1980	2
1981	3
1982	2
1983	1
1984	2
1987	1
1988	5
1989	2
1990	1
1991	2
1992	1
1993	4
1996	1
1997	1
1998	1
2000	1
2002	1
2004	2
2005	1
2023	0

1

[Drug-induced hemolytic anemia. Results of consensus conferences].

Habibi B, Solal-Celigny P, Benichou C, Castot A, Danan G, Lagier G, Lavarenne J, Soubrie C. Habibi B, et al. Among authors: soubrie c. Therapie. 1988 Mar-Apr;43(2):117-20. Therapie. 1988. PMID: 3043755 Review. French. No abstract available.

2

[Iatrogenic disease].

Soubrié C, Lebrun-Vignes B. Soubrié C, et al. Rev Prat. 2005 Jan 31;55(2):209-16. Rev Prat. 2005. PMID: 15826006 Review. French. No abstract available.

3

Tardive dystonia induced by atypical neuroleptics: a case report with olanzapine.

Charfi F, Cohen D, Houeto JL, Soubrié C, Mazet P. Charfi F, et al. Among authors: soubrie c. J Child Adolesc Psychopharmacol. 2004 Spring;14(1):149-52. doi: 10.1089/104454604773840607. J Child Adolesc Psychopharmacol. 2004. PMID: 15142403 Review.

4

[Toxicology of reproduction: predictive value of experimental models. Round Table No 1 at Giens XIII].

Guittin P, Soubrié C, Autret E, Boutemy C, Eléfant E, Jacqz-Aigrain E, Le Bigot JF, Marmor D, Marzin D, Pallardy M, Roux C, Saint Salvi B, Siou G, Soufir JC, Spézia F, Stadler J. Guittin P, et al. Among authors: soubrie c. Therapie. 1998 Jul-Aug;53(4):355-63. Therapie. 1998. PMID: 9806005 Review. French.

5

[Extrapyramidal syndrome during treatment with flunarizine].

Bakchine S, Lacomblez L, Soubrié C. Bakchine S, et al. Among authors: soubrie c. Rev Neurol (Paris). 1988;144(12):833-4. Rev Neurol (Paris). 1988. PMID: 3070697 Review. French.

6

[Methods of adverse drug reaction monitoring. I,Collection of data and type of studies (author's transl)].

Spriet-Pourra C, Spriet A, Soubrie C, Simon P. Spriet-Pourra C, et al. Among authors: soubrie c. Therapie. 1981 Nov-Dec;36(6):609-18. Therapie. 1981. PMID: 7043773 Review. French. No abstract available.

7

Problem-oriented drug information.

Soubrie C, Simon P. Soubrie C, et al. Lancet. 1984 Jan 14;1(8368):106. doi: 10.1016/s0140-6736(84)90036-9. Lancet. 1984. PMID: 6140406 No abstract available.

8

[Drug therapy observation].

Soubrié C. Soubrié C. Rev Infirm. 1991 Nov 7;41(17):55-6. Rev Infirm. 1991. PMID: 1767226 French. No abstract available.

9

Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France.

Billette de Villemeur T, Deslys JP, Pradel A, Soubrié C, Alpérovitch A, Tardieu M, Chaussain JL, Hauw JJ, Dormont D, Ruberg M, Agid Y. Billette de Villemeur T, et al. Among authors: soubrie c. Neurology. 1996 Sep;47(3):690-5. doi: 10.1212/wnl.47.3.690. Neurology. 1996. PMID: 8797466

10

Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects.

Haïk S, Brandel JP, Salomon D, Sazdovitch V, Delasnerie-Lauprêtre N, Laplanche JL, Faucheux BA, Soubrié C, Boher E, Belorgey C, Hauw JJ, Alpérovitch A. Haïk S, et al. Among authors: soubrie c. Neurology. 2004 Dec 28;63(12):2413-5. doi: 10.1212/01.wnl.0000148596.15681.4d. Neurology. 2004. PMID: 15623716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year